Sponsored by an educational grant from Epizyme, Inc. During Blood Cancer Awareness Month this September, Men’s Health Network (MHN) is highlighting follicular lymphoma (FL), a slow-growing blood cancer which accounts for approximately 20 percent of all non-Hodgkin lymphoma (NHL) cases in the United States.[i] We spoke with Bob Mesloh, who was diagnosed with FL more...Continue reading
Tag: epizyme
Spotlighting Follicular Lymphoma for Blood Cancer Awareness Month
Sponsored by an educational grant from Epizyme, Inc. September marks an important awareness milestone for the blood cancer community –Blood Cancer Awareness Month. Men’s Health Network (MHN) is taking the opportunity to spotlight follicular lymphoma (FL), a blood cancer that accounts for approximately 20 percent of all non-Hodgkin lymphoma (NHLs) cases in the United States.[i]...Continue reading